dualyx

Technologiepark-Zwijnaarde 94

9052 Gent

BE

dualyx

Foundation date

21/11/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

dualyx NV focuses on the discovery and development of highly innovative biologicals for the treatment of autoimmune and rare diseases. We aim to create long-lasting treatments for patients with a high unmet medical need.

Upcoming events

Latest news

  • Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China

    1 day ago

  • Celyad announces management change

    Friday December 1st 2023

  • Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States

    Thursday November 30th 2023